GLIPR1L2
gene geneOn this page
Also known as MGC39497
Summary
GLIPR1L2 (GLIPR1 like 2, HGNC:28592) is a protein-coding gene on chromosome 12q21.2, encoding GLIPR1-like protein 2 (Q4G1C9).
This gene encodes a member of the cysteine-rich secretory protein, antigen 5, and pathogenesis-related 1 superfamily. Members of this family have roles in a variety of processes, including cancer and immune defense. This gene is located in a cluster with two related genes on chromosome 12. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 144321 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 61 total
- MANE Select transcript:
NM_001270396
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28592 |
| Approved symbol | GLIPR1L2 |
| Name | GLIPR1 like 2 |
| Location | 12q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC39497 |
| Ensembl gene | ENSG00000180481 |
| Ensembl biotype | protein_coding |
| OMIM | 610394 |
| Entrez | 144321 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 protein_coding
ENST00000320460, ENST00000378692, ENST00000547164, ENST00000550916, ENST00000906733
RefSeq mRNA: 2 — MANE Select: NM_001270396
NM_001270396, NM_152436
CCDS: CCDS58258, CCDS9010
Canonical transcript exons
ENST00000550916 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001241280 | 75413598 | 75413701 |
| ENSE00002356768 | 75391089 | 75391350 |
| ENSE00002372073 | 75430824 | 75432688 |
| ENSE00003477980 | 75422904 | 75422989 |
| ENSE00003518556 | 75430715 | 75430741 |
| ENSE00003664729 | 75410434 | 75410679 |
Expression profiles
Bgee: expression breadth ubiquitous, 132 present calls, max score 87.72.
FANTOM5 (CAGE): breadth broad, TPM avg 1.4061 / max 139.3853, expressed in 461 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 126900 | 1.4061 | 461 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 87.72 | gold quality |
| testis | UBERON:0000473 | 87.68 | gold quality |
| right testis | UBERON:0004534 | 86.54 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.82 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.74 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 77.55 | gold quality |
| substantia nigra | UBERON:0002038 | 74.59 | gold quality |
| islet of Langerhans | UBERON:0000006 | 73.11 | gold quality |
| amygdala | UBERON:0001876 | 72.77 | gold quality |
| temporal lobe | UBERON:0001871 | 72.57 | gold quality |
| putamen | UBERON:0001874 | 72.28 | gold quality |
| nucleus accumbens | UBERON:0001882 | 71.92 | gold quality |
| Ammon’s horn | UBERON:0001954 | 71.50 | gold quality |
| sural nerve | UBERON:0015488 | 71.42 | gold quality |
| hypothalamus | UBERON:0001898 | 71.17 | gold quality |
| caudate nucleus | UBERON:0001873 | 70.95 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 68.85 | gold quality |
| ventricular zone | UBERON:0003053 | 68.70 | gold quality |
| left ovary | UBERON:0002119 | 68.61 | gold quality |
| ovary | UBERON:0000992 | 68.42 | gold quality |
| brain | UBERON:0000955 | 67.92 | gold quality |
| cortical plate | UBERON:0005343 | 67.80 | gold quality |
| muscle tissue | UBERON:0002385 | 67.60 | gold quality |
| prefrontal cortex | UBERON:0000451 | 67.40 | gold quality |
| cerebral cortex | UBERON:0000956 | 67.40 | gold quality |
| primary visual cortex | UBERON:0002436 | 67.33 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 66.91 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 66.78 | gold quality |
| endocervix | UBERON:0000458 | 66.48 | gold quality |
| frontal cortex | UBERON:0001870 | 66.40 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-89 | no | 275.43 |
| E-ANND-3 | no | 4.96 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
63 targeting GLIPR1L2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-6798-5P | 100.00 | 65.77 | 699 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-5003-3P | 99.85 | 69.29 | 2517 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-6505-5P | 99.73 | 69.25 | 1595 |
| HSA-MIR-1179 | 99.71 | 68.70 | 1040 |
| HSA-MIR-4699-3P | 99.71 | 70.15 | 3142 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-7156-5P | 99.64 | 68.81 | 1369 |
| HSA-MIR-4499 | 99.62 | 67.29 | 1470 |
| HSA-MIR-17-3P | 99.55 | 66.77 | 1311 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-12131 | 99.48 | 68.72 | 1673 |
| HSA-MIR-548G-3P | 99.48 | 68.67 | 2159 |
Cross-species orthologs
54 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | glipr1b | ENSDARG00000030078 |
| danio_rerio | glipr2 | ENSDARG00000041724 |
| danio_rerio | glipr1a | ENSDARG00000045224 |
| danio_rerio | ENSDARG00000103034 | |
| danio_rerio | im:7150988 | ENSDARG00000109310 |
| mus_musculus | Glipr1l2 | ENSMUSG00000020214 |
| rattus_norvegicus | Glipr1l2 | ENSRNOG00000049053 |
| drosophila_melanogaster | Ag5r | FBGN0015010 |
| drosophila_melanogaster | Ag5r2 | FBGN0020508 |
| drosophila_melanogaster | CG9400 | FBGN0030562 |
| drosophila_melanogaster | CG4270 | FBGN0031407 |
| drosophila_melanogaster | CG16995 | FBGN0031412 |
| drosophila_melanogaster | CG10651 | FBGN0032853 |
| drosophila_melanogaster | CG9822 | FBGN0034623 |
| drosophila_melanogaster | CG17974 | FBGN0034624 |
| drosophila_melanogaster | CG3640 | FBGN0035042 |
| drosophila_melanogaster | CG8072 | FBGN0036070 |
| drosophila_melanogaster | CG6628 | FBGN0036072 |
| drosophila_melanogaster | scpr-C | FBGN0037879 |
| drosophila_melanogaster | scpr-B | FBGN0037888 |
| drosophila_melanogaster | scpr-A | FBGN0037889 |
| drosophila_melanogaster | CG8483 | FBGN0038126 |
| drosophila_melanogaster | CG30486 | FBGN0050486 |
| drosophila_melanogaster | antr | FBGN0050488 |
| drosophila_melanogaster | CG31286 | FBGN0051286 |
| drosophila_melanogaster | CG32313 | FBGN0052313 |
| drosophila_melanogaster | CG32679 | FBGN0052679 |
| drosophila_melanogaster | CG34002 | FBGN0054002 |
| drosophila_melanogaster | CG34049 | FBGN0054049 |
| drosophila_melanogaster | CG17575 | FBGN0250842 |
| drosophila_melanogaster | CG42564 | FBGN0260766 |
| drosophila_melanogaster | CG42780 | FBGN0261848 |
| drosophila_melanogaster | CG43775 | FBGN0264297 |
| drosophila_melanogaster | CG43776 | FBGN0264298 |
| drosophila_melanogaster | CG43777 | FBGN0264299 |
| caenorhabditis_elegans | WBGENE00004742 | |
| caenorhabditis_elegans | WBGENE00007397 | |
| caenorhabditis_elegans | WBGENE00008027 | |
| caenorhabditis_elegans | WBGENE00008028 | |
| caenorhabditis_elegans | WBGENE00008029 | |
| caenorhabditis_elegans | WBGENE00008030 | |
| caenorhabditis_elegans | WBGENE00008625 | |
| caenorhabditis_elegans | WBGENE00009891 | |
| caenorhabditis_elegans | WBGENE00009895 | |
| caenorhabditis_elegans | WBGENE00009896 | |
| caenorhabditis_elegans | WBGENE00012816 | |
| caenorhabditis_elegans | WBGENE00013971 | |
| caenorhabditis_elegans | WBGENE00013972 | |
| caenorhabditis_elegans | WBGENE00015246 | |
| caenorhabditis_elegans | WBGENE00017055 | |
| caenorhabditis_elegans | WBGENE00017183 | |
| caenorhabditis_elegans | WBGENE00019178 | |
| caenorhabditis_elegans | WBGENE00019179 | |
| caenorhabditis_elegans | WBGENE00021780 |
Paralogs (13): CRISP3 (ENSG00000096006), R3HDML (ENSG00000101074), CRISPLD2 (ENSG00000103196), CRISPLD1 (ENSG00000121005), GLIPR2 (ENSG00000122694), CRISP2 (ENSG00000124490), CRISP1 (ENSG00000124812), PI15 (ENSG00000137558), GLIPR1 (ENSG00000139278), CLEC18B (ENSG00000140839), CLEC18A (ENSG00000157322), CLEC18C (ENSG00000157335), GLIPR1L1 (ENSG00000173401)
Protein
Protein identifiers
GLIPR1-like protein 2 — Q4G1C9 (reviewed: Q4G1C9)
All UniProt accessions (1): Q4G1C9
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Tissue specificity. Highly expressed in testis. Detected in prostate, kidney, bladder, lung and bone marrow.
Induction. Up-regulated by doxycycline.
Similarity. Belongs to the CRISP family.
Isoforms (6)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q4G1C9-1 | 1, delta | yes |
| Q4G1C9-2 | 2, alpha | |
| Q4G1C9-3 | 3 | |
| Q4G1C9-4 | 4, epsilon | |
| Q4G1C9-5 | 5, gamma | |
| Q4G1C9-6 | 6, beta |
RefSeq proteins (2): NP_001257325, NP_689649 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001283 | CRISP-related | Family |
| IPR014044 | CAP_dom | Domain |
| IPR034121 | SCP_GLIPR-1-like | Domain |
| IPR035940 | CAP_sf | Homologous_superfamily |
Pfam: PF00188
UniProt features (15 total): splice variant 8, compositionally biased region 3, chain 1, transmembrane region 1, domain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q4G1C9-F1 | 85.40 | 0.59 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 67 (showing top):
MARTINEZ_RB1_TARGETS_DN, chr12q21, FIGUEROA_AML_METHYLATION_CLUSTER_3_UP, E2F2_TARGET_GENES, EMX1_TARGET_GENES, HAND1_TARGET_GENES, HOXB4_TARGET_GENES, HOXD1_TARGET_GENES, LHX9_TARGET_GENES, MAFG_TARGET_GENES, RYBP_TARGET_GENES, TAFAZZIN_TARGET_GENES, ZBTB12_TARGET_GENES, ZNF660_TARGET_GENES, ZNF664_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): obsolete extracellular space (GO:0005615), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
402 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GLIPR1L2 | SPATA17 | Q96L03 | 499 |
| GLIPR1L2 | DHRS13 | Q6UX07 | 466 |
| GLIPR1L2 | TP53 | P04637 | 463 |
| GLIPR1L2 | ATF7IP2 | Q5U623 | 454 |
| GLIPR1L2 | FRY | Q5TBA9 | 453 |
| GLIPR1L2 | SUPT16H | Q9Y5B9 | 433 |
| GLIPR1L2 | SCN3A | Q9NY46 | 424 |
| GLIPR1L2 | PTK7 | Q13308 | 415 |
| GLIPR1L2 | CACNA1G | O43497 | 409 |
| GLIPR1L2 | ARID1B | Q8NFD5 | 401 |
| GLIPR1L2 | ZNF98 | A6NK75 | 392 |
| GLIPR1L2 | N4BP2L1 | Q5TBK1 | 388 |
| GLIPR1L2 | TMEM14B | Q9NUH8 | 366 |
| GLIPR1L2 | TRIP12 | Q14669 | 361 |
| GLIPR1L2 | DEXI | O95424 | 360 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GLIPR1L2 | PPP1CA | psi-mi:“MI:0915”(physical association) | 0.370 |
| GLIPR1L2 | ZZEF1 | psi-mi:“MI:0914”(association) | 0.350 |
| GLIPR1L2 | PROS1 | psi-mi:“MI:0914”(association) | 0.350 |
| GLIPR1L2 | SEC24B | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (33): ARMC8 (Affinity Capture-MS), ZZEF1 (Affinity Capture-MS), MAEA (Affinity Capture-MS), MKLN1 (Affinity Capture-MS), RMND5A (Affinity Capture-MS), RANBP10 (Affinity Capture-MS), RANBP9 (Affinity Capture-MS), GID4 (Affinity Capture-MS), ZMYND19 (Affinity Capture-MS), RANBP10 (Affinity Capture-MS), GID4 (Affinity Capture-MS), MKLN1 (Affinity Capture-MS), ZZEF1 (Affinity Capture-MS), MAEA (Affinity Capture-MS), SNX11 (Affinity Capture-MS)
ESM2 similar proteins: A6QLZ7, D5K8A9, F8VQ03, H2QAR5, O77681, O95727, P0DV84, P14151, P30836, P35070, P48060, P51170, P97793, Q05928, Q0II64, Q149L7, Q28GB8, Q32LB5, Q4G1C9, Q4V9Y5, Q568T5, Q5XIG2, Q6PEW0, Q6UWM5, Q6UXB8, Q7M756, Q7T2X6, Q8BZQ2, Q8C0L0, Q8C351, Q8CGD2, Q8IUX8, Q91620, Q95237, Q98936, Q98ST5, Q9BXP8, Q9CQ35, Q9CWG1, Q9DA48
Diamond homologs: A2A5I3, A5D8T8, A6MFK9, A6QLZ7, A8S6B6, B0VXV6, B2MVK7, B7FDI0, B7FDI1, F8J2D4, F8S0Y4, G3CJR9, O19010, O43692, P07053, P08299, P09042, P0CB15, P0DMB9, P0DMT4, P0DPU0, P0DPU1, P0DPV2, P10737, P16562, P35760, P35780, P35781, P35782, P35783, P35784, P35785, P35786, P35787, P48060, P54108, P60623, P79845, P81657, P84805
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
61 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 55 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
872 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:75413597:GCTT:G | acceptor_gain | 1.0000 |
| 12:75415706:T:A | acceptor_gain | 1.0000 |
| 12:75422895:T:TA | acceptor_gain | 1.0000 |
| 12:75422899:TGTA:T | acceptor_loss | 1.0000 |
| 12:75422900:GTA:G | acceptor_loss | 1.0000 |
| 12:75422902:A:AG | acceptor_gain | 1.0000 |
| 12:75422902:AGAG:A | acceptor_gain | 1.0000 |
| 12:75422903:G:GT | acceptor_gain | 1.0000 |
| 12:75422903:GA:G | acceptor_gain | 1.0000 |
| 12:75422903:GAGG:G | acceptor_gain | 1.0000 |
| 12:75422903:GAGGA:G | acceptor_gain | 1.0000 |
| 12:75391282:GA:G | donor_gain | 0.9900 |
| 12:75391284:G:GG | donor_gain | 0.9900 |
| 12:75391331:GGTC:G | donor_gain | 0.9900 |
| 12:75391360:G:GT | donor_gain | 0.9900 |
| 12:75403015:A:AG | acceptor_gain | 0.9900 |
| 12:75403016:G:GG | acceptor_gain | 0.9900 |
| 12:75403016:GTT:G | acceptor_gain | 0.9900 |
| 12:75403016:GTTAT:G | acceptor_gain | 0.9900 |
| 12:75409250:G:GT | donor_gain | 0.9900 |
| 12:75410540:AT:A | acceptor_gain | 0.9900 |
| 12:75410541:T:TA | acceptor_gain | 0.9900 |
| 12:75413596:A:AG | acceptor_gain | 0.9900 |
| 12:75413597:G:GG | acceptor_gain | 0.9900 |
| 12:75413700:GG:G | donor_gain | 0.9900 |
| 12:75413701:GG:G | donor_gain | 0.9900 |
| 12:75415736:T:TA | acceptor_gain | 0.9900 |
| 12:75422751:G:T | donor_gain | 0.9900 |
| 12:75422774:G:GG | donor_gain | 0.9900 |
| 12:75422899:T:TA | acceptor_gain | 0.9900 |
AlphaMissense
2286 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:75410439:G:C | W80C | 0.999 |
| 12:75410439:G:T | W80C | 0.999 |
| 12:75410437:T:A | W80R | 0.998 |
| 12:75410437:T:C | W80R | 0.998 |
| 12:75410610:G:C | W137C | 0.998 |
| 12:75410610:G:T | W137C | 0.998 |
| 12:75413686:G:A | C190Y | 0.998 |
| 12:75410441:A:T | D81V | 0.997 |
| 12:75413625:G:T | G170C | 0.997 |
| 12:75413628:T:A | C171S | 0.997 |
| 12:75413629:G:C | C171S | 0.997 |
| 12:75413685:T:A | C190S | 0.997 |
| 12:75413686:G:C | C190S | 0.997 |
| 12:75413687:C:G | C190W | 0.997 |
| 12:75430849:G:C | W241C | 0.997 |
| 12:75430849:G:T | W241C | 0.997 |
| 12:75410456:G:C | R86P | 0.996 |
| 12:75410581:T:C | F128L | 0.996 |
| 12:75410583:T:A | F128L | 0.996 |
| 12:75410583:T:G | F128L | 0.996 |
| 12:75410608:T:A | W137R | 0.996 |
| 12:75410608:T:C | W137R | 0.996 |
| 12:75422986:T:A | C223S | 0.996 |
| 12:75422987:G:C | C223S | 0.996 |
| 12:75410462:C:A | A88D | 0.995 |
| 12:75410482:T:A | C95S | 0.995 |
| 12:75410483:G:C | C95S | 0.995 |
| 12:75410582:T:G | F128C | 0.995 |
| 12:75413626:G:A | G170D | 0.995 |
| 12:75413628:T:C | C171R | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000015122 (12:75397258 CT>C,CTT), RS1000042437 (12:75405769 T>A), RS1000070471 (12:75431957 A>C), RS1000122458 (12:75419390 A>G), RS1000233712 (12:75404511 A>G), RS1000411016 (12:75400526 A>G,T), RS1000492341 (12:75414435 A>G), RS1000603977 (12:75429420 A>G), RS1000646203 (12:75407106 C>T), RS1000706590 (12:75394280 A>G,T), RS1000731678 (12:75423905 T>C), RS1000774927 (12:75414171 T>C), RS1000777664 (12:75407662 G>A,T), RS1000844033 (12:75405805 A>G), RS1000949589 (12:75399542 C>T)
Disease associations
OMIM: gene MIM:610394 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003518_77 | Daytime sleep phenotypes | 8.000000e-06 |
| GCST012490_431 | Femur bone mineral density x serum urate levels interaction | 2.000000e-08 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007828 | daytime rest measurement |
| EFO:0004531 | urate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol F | affects cotreatment, increases expression | 1 |
| bisphenol A | affects cotreatment, increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression, affects cotreatment | 1 |
| pentanal | decreases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Lipopolysaccharides | affects response to substance, increases expression, affects cotreatment | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.